Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1994-9-27
|
pubmed:abstractText |
Based on our studies on the enzymatic modifications of arbekacin by methicillin-resistant Staphylococcus aureus (MRSA), replacement of the 2''-hydroxyl group by an amino group in arbekacin was designed to synthesize derivatives that would be active against MRSA. 2''-Amino-2''-deoxyarbekacin and five analogs were synthesized starting from dibekacin. Among them, 2''-amino-2''-deoxyarbekacin and the 5-epiamino analog showed excellent antibacterial activities against not only MRSA but also Gram-negative bacteria including Pseudomonas, and lower toxicities than arbekacin.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0021-8820
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
821-32
|
pubmed:dateRevised |
2000-12-18
|
pubmed:meshHeading |
pubmed-meshheading:8071128-Carbohydrate Sequence,
pubmed-meshheading:8071128-Dibekacin,
pubmed-meshheading:8071128-Gram-Negative Bacteria,
pubmed-meshheading:8071128-Magnetic Resonance Spectroscopy,
pubmed-meshheading:8071128-Methicillin Resistance,
pubmed-meshheading:8071128-Microbial Sensitivity Tests,
pubmed-meshheading:8071128-Molecular Sequence Data,
pubmed-meshheading:8071128-Staphylococcus,
pubmed-meshheading:8071128-Staphylococcus aureus,
pubmed-meshheading:8071128-Structure-Activity Relationship
|
pubmed:year |
1994
|
pubmed:articleTitle |
Synthesis of 2''-amino-2''-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus.
|
pubmed:affiliation |
Institute of Microbial Chemistry, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|